Trials / Completed
CompletedNCT00426010
Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
Measuring Placebo Effect by Elimination and Investigating Its Mechanism of Action
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
We propose to measure the effect of placebo by elimination as well as by a "balanced placebo" design, determine its interaction with active drug, and explore whether placebo exerts part of its effect at the pharmacokinetics level.
Detailed description
Placebos have been in use for centuries in medical practice. However, there is continued controversy regarding their effectiveness and mechanisms of action. The results of the study are expected to further our understanding of a widely used medical intervention, i.e., placebo, and of how to maximize its potential beneficial effect. It will also help assess the appropriateness of measuring the placebo effect by elimination, which has important ethical implications in relation to the design of randomized clinical trials. Comparison: caffeine vs placebo. Dependent variables:4 hours area under the curve (AUC) of pharmacodynamics endpoints as well as pharmacokinetics endpoints in a subgroup.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | caffeine/placebo | caffeine or placebo, either overt or covert |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2007-01-24
- Last updated
- 2011-12-13
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT00426010. Inclusion in this directory is not an endorsement.